Bg pattern

IBANDRONIC ACID SANDOZ 150 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use IBANDRONIC ACID SANDOZ 150 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Ibandronic Acid Sandoz 150 mg Film-Coated Tablets EFG

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What Ibandronic Acid Sandoz is and what it is used for
  2. What you need to know before you take Ibandronic Acid Sandoz
  3. How to take Ibandronic Acid Sandoz
  4. Possible side effects
  5. Storage of Ibandronic Acid Sandoz
  6. Contents of the pack and other information

1. What Ibandronic Acid Sandoz is and what it is used for

Ibandronic Acid Sandoz belongs to a group of medicines called bisphosphonates.

It contains the active substance ibandronic acid. Ibandronic acid can reverse bone loss because it prevents further bone loss and increases bone mass in most women who take it, even if they cannot see or feel the difference. Ibandronic acid may help reduce the risk of broken bones (fractures). This reduction has been shown in spinal fractures but not in hip fractures.

You have been prescribed ibandronic acid to treat your postmenopausal osteoporosis because you are at high risk of fractures.Osteoporosis is a condition where your bones become thin and weak, which is common in women after the menopause. During the menopause, the ovaries stop producing the female hormone, estrogen, which helps to keep your skeleton healthy.

The earlier a woman reaches the menopause, the greater her risk of fractures due to osteoporosis.

Other factors that increase the risk of fractures include:

  • inadequate intake of calcium and vitamin D in the diet,
  • smoking or excessive alcohol consumption,
  • lack of weight-bearing exercise,
  • family history of osteoporosis.

Healthy lifestyle habitsalso help the beneficial effects of treatment. These include:

  • a balanced diet rich in calcium and vitamin D,
  • weight-bearing exercise,

not smoking, and moderate alcohol consumption.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Ibandronic Acid Sandoz

Do not take Ibandronic Acid Sandoz

  • if you are allergic to ibandronic acid or any of the other ingredients of this medicine (listed in section 6),
  • if you have certain problems with your throat/food pipe (esophagus) such as narrowing or difficulty swallowing,
  • if you cannot stand or sit upright for at least one hour (60 minutes),
  • if you have or have had low blood calcium levels.Please consult your doctor.

Warnings and precautions

A very rare side effect called osteonecrosis of the jaw (ONJ) (bone damage in the jaw) has been reported in patients treated with ibandronic acid for osteoporosis. ONJ can also occur after stopping treatment.

It is important to try to prevent ONJ from developing as it can be a painful condition that can be difficult to treat. To reduce the risk of developing osteonecrosis of the jaw, certain precautions need to be taken.

Atypical fractures of long bones, such as the forearm (ulna) and lower leg (tibia), have also been reported in patients receiving long-term treatment with ibandronate. These fractures occur after minimal or no trauma and some patients experience pain in the area of the fracture before a complete fracture occurs.

Before receiving treatment, inform your doctor/nurse (healthcare professional) if:

  • you have dental problems or are about to undergo dental surgery,
  • you do not receive regular dental check-ups or have not had a dental check-up for a long time,
  • you are a smoker (as this may increase the risk of dental problems),
  • you have been treated with a bisphosphonate (used to treat or prevent bone disorders) before,
  • you are taking medicines called corticosteroids (such as prednisolone or dexamethasone),
  • you have cancer.

Your doctor may ask you to have a dental check-up before starting treatment with ibandronic acid.

While you are being treated, you should maintain good oral hygiene (including regular tooth brushing) and have regular dental check-ups. If you wear dentures, you should make sure they fit properly. If you are undergoing dental treatment or are about to undergo dental surgery (e.g. tooth extraction), inform your doctor about your dental treatment and inform your dentist that you are being treated with ibandronic acid.

Contact your doctor and dentist immediately if you experience any problems with your mouth or teeth, such as tooth loss, pain, or swelling, or difficulty healing of mouth ulcers or discharge, as these could be signs of osteonecrosis of the jaw.

Some people need special care when taking ibandronic acid. Consult your doctor:

  • if you have any mineral metabolism disorders (e.g. vitamin D deficiency),
  • if you have any kidney problems,
  • if you have any swallowing or digestive problems.

Irritation, inflammation, or ulcers of the throat/food pipe (esophagus) may occur, often with symptoms of severe chest pain, severe pain after swallowing food and/or drink, severe nausea, or vomiting, especially if patients do not drink a full glass of water and/or if they lie down less than 60 minutes after taking ibandronic acid. If you develop these symptoms, stop taking ibandronic acid and inform your doctor immediately (see section 3).

Children and adolescents

Do not give Ibandronic Acid Sandoz to children or adolescents under 18 years of age.

Using Ibandronic Acid Sandoz with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. Especially if you are taking:

  • Supplements containing calcium, magnesium, iron, or aluminumas they may interfere with the effects of ibandronic acid.
  • Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) (such as ibuprofen, diclofenac sodium, and naproxen) as they may irritate the stomach and intestines, as does ibandronic acid. Therefore, be careful when taking painkillers or anti-inflammatory drugs at the same time as ibandronic acid.

After taking the monthly ibandronic acid tablet, wait 1 hour before taking any other medicine, even antacids, calcium supplements, or vitamins.

Taking Ibandronic Acid Sandoz with food and drinks

Do not takeibandronic acid with food. Ibandronic acid loses effectiveness if taken with food.

You can drink water but no other liquids.

After taking Ibandronic Acid Sandoz, please wait 1 hour before taking your first food and drink (see section 3 "How to take Ibandronic Acid Sandoz").

Pregnancy and breastfeeding

Ibandronic Acid Sandoz is only for use in postmenopausal women and must not be taken by women of childbearing potential. Do not take ibandronic acid if you are pregnant or breastfeeding.

Consult your doctor or pharmacist before using this medicine.

Driving and using machines

You can drive and use machines as ibandronic acid is not expected to have a significant or negligible effect on the ability to drive and use machines.

Ibandronic Acid Sandoz contains lactose and sodium

This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

This medicine contains less than 1 mmol (23 mg) of sodium per film-coated tablet; this is essentially "sodium-free".

3. How to take Ibandronic Acid Sandoz

Follow the instructions for administration of ibandronic acid exactly as your doctor has told you. Ask your doctor or pharmacist if you are unsure.

The recommended dose of ibandronic acid is one tablet once a month.

How to take the monthly tablet

It is important that you follow these instructions carefully. They are designed to help ibandronic acid reach the stomach quickly and cause less irritation.

  • Take one Ibandronic Acid Sandoz 150 mg tablet once a month.
  • Choose a day of the monththat you can easily remember. You can choose the same date (e.g. the first day of each month) or always the same day (e.g. the first Sunday of each month). Choose what best fits your routine.
  • Take the ibandronic acid tablet at least 6 hours after your last food or drink, except water.
  • Take the ibandronic acid tablet,
  • immediately after waking up, and
  • before breakfast or drinking(on an empty stomach).
  • Swallow the tablet with a full glass of water(at least 180 ml).

Do nottake the tablet with water that has a high calcium content, fruit juice, or other drinks. If there is concern about potentially high calcium levels in the water (hard water), it is recommended to use bottled water with a low mineral content.

  • Swallow the tablet whole, do not chew, crush, or dissolve it in your mouth.
  • During the next hour (60 minutes)after taking the tablet
  • do not lie down; if you do not remain upright (standing or sitting), some of the medicine could come back up into your esophagus,

Bed with a person lying down crossed out with a thick blue cross indicating prohibition

  • do not eat anything,

Plate with fork and knife crossed out with a thick blue cross indicating prohibition or restriction

  • do not drink anything(except water if needed),
  • do not take any other medicine.
  • After waiting 1 hour, you can have your breakfast and your first drink of the day. Once you have eaten, you can lie down and take any other medicines you need.

Continuation of treatment with Ibandronic Acid Sandoz

It is important that you take ibandronic acid every month, until your doctor tells you to stop. After 5 years of treatment with Ibandronic Acid Sandoz, contact your doctor to find out if you should continue treatment with Ibandronic Acid Sandoz.

If you take more Ibandronic Acid Sandoz than you should

If you have taken more than one tablet by mistake, drink a full glass of milk and contact your doctor immediately.

Do not induce vomiting or lie downas this could cause ibandronic acid to irritate your esophagus.

If you forget to take Ibandronic Acid Sandoz

If you forget to take the tablet on the morning of the day you have chosen, do not take the tablet later. Instead, consult your calendar to see when your next dose is due:

  • If you forget your dose on the scheduled day and your next dose is within 1 to 7 days

Never take two Ibandronic Acid Sandoz tablets within the same week.Wait until your next scheduled dose and take it as usual, then continue taking one tablet per month according to the days marked on your calendar.

  • If you forget your dose on the scheduled day and your next dose is more than 7 days away

Take a tablet the next morning after the day you remember you forgot your dose, then continue taking one tablet per month according to the days marked on your calendar.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, stating the medicine and the amount taken.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell a nurse or doctor immediately if you notice any of the following serious side effects - you may need urgent medical treatment:

Uncommon(may affect up to 1 in 100 people):

  • Severe chest pain, severe pain after swallowing food or drink, severe nausea, or vomiting, difficulty swallowing. You may have severe inflammation of the throat/esophagus, possibly with ulcers or narrowing of the throat or esophagus.

Rare(may affect up to 1 in 1,000 people):

  • itching, swelling of the face, lips, tongue, and throat, with difficulty breathing,
  • persistent eye pain and inflammation,
  • new pain, weakness, or discomfort in the thigh, hip, or groin. You may be experiencing the first signs of a possible unusual fracture of the thigh bone.

Very rare(may affect up to 1 in 10,000 people):

  • pain or ulcers in the mouth or jaw. These can be early symptoms of serious jaw problems (necrosis (death of bone tissue) of the jawbone),
  • severe allergic reaction or potentially life-threatening allergic reaction,
  • severe skin reactions,
  • consult your doctor if you have ear pain, discharge from the ear, and/or an ear infection. These could be symptoms of damage to the bones of the ear.

Other possible side effects

Common(may affect up to 1 in 10 people):

  • headache,
  • heartburn, difficulty swallowing, stomach pain or discomfort (may be due to stomach inflammation), indigestion, nausea, diarrhea, bowel movements
  • muscle cramps, stiffness in the joints and limbs.
  • flu-like symptoms, including fever, chills, and shivers, bone, muscle, and joint pain. Talk to a doctor or nurse if the effects worsen or last more than a couple of days,
  • rash.

Uncommon(may affect up to 1 in 100 people):

  • dizziness,
  • bloating (gas, feeling bloated)
  • back pain,
  • feeling tired and weak,
  • asthma attacks,
  • symptoms of low calcium levels in the blood (hypocalcemia), including muscle cramps or spasms and/or tingling sensation in the fingers or around the mouth.

Rare(may affect up to 1 in 1,000 people):

  • inflammation of the duodenum (first section of the intestine) causing stomach pain,
  • hives.

Reporting of side effects:

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Ibandronic Acid Sandoz

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date is the last day of the month shown.

No special storage conditions are required.

Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to a pharmacy for disposal. If you are unsure, ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Packaging Contents and Additional Information

Composition of Acid Ibandronic Sandoz

  • The active ingredient is ibandronic acid. One film-coated tablet contains 150 mg of ibandronic acid (as sodium ibandronate monohydrate).
  • The other ingredients are:

Core: povidone, microcrystalline cellulose, pregelatinized maize starch, crospovidone, anhydrous colloidal silica, glycerol dibehenate.

Coating: hypromellose, lactose monohydrate, titanium dioxide (E171), macrogol 4000.

Appearance and Packaging of the Product

White, round, and biconvex film-coated tablets.

Acid Ibandronic Sandoz is presented in a cardboard package containing an appropriate number of blisters (1, 3, or 6 tablets) PA/Aluminum/PVC-Aluminum (Alu-Alu blister) and a leaflet.

Only some pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Sandoz Pharmaceutical, S.A.

Centro Empresarial Parque Norte

Edificio Roble

C/ Serrano Galvache, 56

28033 Madrid

Spain

Manufacturer

LEK S.A.

ul. Domaniewska 50 C,

PL-02-672 Warszawa

Poland

or

Pharmathen S.A.

6 Dervenakion Str.,

153 51 Pallini, Attiki,

Greece

or

Lek pharmaceuticals d.d.

Verovskova 57

1526 Ljubljana

Slovenia

or

S.C. Sandoz, S.R.L.

Str. Livezeni nr. 7ª

RO-540472 Targu-Mures

Romania

or

Salutas Pharma GmbH

Otto-von-Guericke-Allee 1

39179 Barleben

Germany

or

Lek Pharmaceuticals d.d.

Trimlini 2D

9220 Lendava

Slovenia

or

Pharmathen International, S.A.

Sapes Industrial Park, Block 5

69300 Rodopi

Greece

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Belgium: Ibandronic acid Sandoz 150 mg film-coated tablets

Italy: Acido Ibandronico Sandoz 150 mg coated tablets

Netherlands: Ibandroninezuur Sandoz 150 mg, film-coated tablets

Portugal: Ácido Ibandrónico Sandoz 150 mg film-coated tablets

Romania: Ibandronic Acid Sandoz 150 mg film-coated tablets

Slovak Republic: Kyselina ibandrónová Sandoz 150mg film-coated tablets

Northern Ireland: Ibandronic acid Sandoz 150mg Film-coated Tablets

Date of the last revision of this leaflet:January 2025

Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for IBANDRONIC ACID SANDOZ 150 mg FILM-COATED TABLETS

Discuss questions about IBANDRONIC ACID SANDOZ 150 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (29)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for IBANDRONIC ACID SANDOZ 150 mg FILM-COATED TABLETS?
IBANDRONIC ACID SANDOZ 150 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in IBANDRONIC ACID SANDOZ 150 mg FILM-COATED TABLETS?
The active ingredient in IBANDRONIC ACID SANDOZ 150 mg FILM-COATED TABLETS is ibandronic acid. This information helps identify medicines with the same composition but different brand names.
How much does IBANDRONIC ACID SANDOZ 150 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for IBANDRONIC ACID SANDOZ 150 mg FILM-COATED TABLETS is around 13 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures IBANDRONIC ACID SANDOZ 150 mg FILM-COATED TABLETS?
IBANDRONIC ACID SANDOZ 150 mg FILM-COATED TABLETS is manufactured by Sandoz Farmaceutica S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of IBANDRONIC ACID SANDOZ 150 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether IBANDRONIC ACID SANDOZ 150 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to IBANDRONIC ACID SANDOZ 150 mg FILM-COATED TABLETS?
Other medicines with the same active substance (ibandronic acid) include ABRION 150 mg FILM-COATED TABLETS, Ibandronic Acid Accord 2 mg concentrate for infusion solution, Ibandronic Acid Accord 6 mg concentrate for infusion solution. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media